Analysis reveals viral shift behind COVID-19 pandemic end

New analysis suggests that a dramatic drop in deaths from COVID-19 between 2022 and 2023 could be attributed to an abrupt phase transition in the molecular structure of the virus’ spike protein.

Q&A: Ken Song details RayzeBio’s path from Series A to IPO in 3 years, taking a down round and being disciplined

Ken Song almost never got into radiopharmaceuticals. But after back-to-back phone calls from venture capital leaders at Versant and venBio in March 2020, the repeat

March 6, 2024

Two reproductive health conditions associated with increasing cardiovascular disease risk in women

Two reproductive health conditions common in women, polycystic ovary syndrome and dysmenorrhea, are each associated with increasing cardiovascular disease risk, according to two preliminary studies

November 6, 2023

Verix Adds Gen AI Database Explorer to Commercial Pharma Optimization

What You Should Know: – Verix, a leader in AI-powered commercial operations solutions for the pharmaceutical industry, has announced the launch of its revolutionary GenAI

March 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.